Seal’s Will Moss explains why chain-of-identity failures threaten patient safety and cell and gene therapy scale-up.
About Take-Two Interactive Software Inc. Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console ...